C. Vibat

发表

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

M. Erlander, H. Wakelee, L. Sequist, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detecting an ALK Rearrangement via Liquid Biopsy Enabled a Targeted Therapy-based Approach for Treating a Patient with Advanced Non-small Cell Lung Cancer

Veena Singh, C. Vibat, A. Calvo, 2018 .

Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations

J. Poole, Veena Singh, T. Lu, 2019, PloS one.

Clinical Utility of Target Selector TM Circulating Tumor Cell ( CTC ) Testing in Tumor Marker Gene Amplification and Protein Expression in Metastatic Breast Cancer Management

K. Tkaczuk, Veena Singh, K. Seale, 2018 .

Identification of the axial heme ligands of cytochrome b 556 in succinate: Ubiquinone oxidoreductase from Escherichia coli

R. Gennis, J. Peterson, C. Vibat, 1994, FEBS letters.

Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population

J. Cuzick, M. Erlander, Amar S. Ahmad, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Two Hydrophobic Subunits Are Essential for the Heme b Ligation and Functional Assembly of Complex II (Succinate-Ubiquinone Oxidoreductase) from Escherichia coli(*)

H. Inokuchi, R. Gennis, T. Nakayashiki, 1996, The Journal of Biological Chemistry.

Demonstrated Clinical Utility of Target SelectorTM ctDNA Testing: Liquid Biopsy eGFR Mutation Detection Enabled Targeted Therapy Selection for Three Advanced NSCLC Patients

R. Erlich, Veena Singh, C. Vibat, 2019 .

One-step purification from Escherichia coli of complex II (succinate: ubiquinone oxidoreductase) associated with succinate-reducible cytochrome b556.

R. Gennis, K. Kita, J. Guest, 1989, The Journal of biological chemistry.

Intracellular Cl regulates Na-K-Cl cotransport activity in human trabecular meshwork cells.

M. O’Donnell, C. Vibat, L. K. Putney, 1999, American journal of physiology. Cell physiology.

Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas.

D. Lockhart, C. Barlow, C. Winrow, 2005, Human molecular genetics.

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.

M. Erlander, J. Baselga, O. Abdel-Wahab, 2015, Cancer discovery.

Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders

M. Erlander, J. Baselga, O. Abdel-Wahab, 2014 .

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

M. Erlander, A. Bardelli, F. Meric-Bernstam, 2017, Clinical Cancer Research.

Localization of histidine residues responsible for heme axial ligation in cytochrome b556 of complex II (succinate:ubiquinone oxidoreductase) in Escherichia coli.

R. Gennis, K. Nakamura, G. Cecchini, 1998, Biochemistry.

Genomic replacement in Escherichia coli K-12 using covalently closed circular plasmid DNA.

R. Gennis, J. Cronan, L. DeVeaux, 1990, Gene.

Prospective prediction of clinical drug response in high-grade gliomas using an ex vivo 3D cell culture assay

Lindsay J. Lipinski, N. Butowski, J. Edenfield, 2021, Neuro-oncology advances.

Quantitation of Na+-K+-2Cl- cotransport splice variants in human tissues using kinetic polymerase chain reaction.

M. Holland, J. Kang, M. O'Donnell, 2001, Analytical biochemistry.

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

M. Erlander, F. Meric-Bernstam, R. Kurzrock, 2014, Oncotarget.

Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer.

M. Erlander, V. Senkomago, J. Smith, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions

M. Erlander, J. Fregnani, A. Longatto-Filho, 2018, Journal of lower genital tract disease.

Non-Invasive Monitoring of Urinary KRAS Circulating Tumor DNA for Treatment Response and Minimal Residual Disease in Patients with Lung Adenocarcinoma.

M. Erlander, S. Lippman, R. Kurzrock, 2015 .

Kinetic monitoring of EGFR T790M in urinary circulating tumor DNA to predict radiographic progression and response in patients with metastatic lung adenocarcinoma.

M. Erlander, S. Lippman, R. Kurzrock, 2015 .

Effect of hypothyroidism and rehabilitation on day and night melatonin levels in pineal, hypothalamus and serum of male rats

M. Catalá, W. B. Quay, P. Timiras, 1987 .

Comparative circulating tumor DNA levels for KRAS mutations in patients with nonresectable pancreatic cancer.

M. Erlander, E. Collisson, B. Jensen, 2015 .

A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma

Holly C. Beale, K. Learned, E. Kephart, 2021, Cells.

Molecular characterization of the Na-K-Cl cotransporter of bovine aortic endothelial cells.

J. A. Payne, M. O’Donnell, Dandan Sun, 1997, The American journal of physiology.

Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed inXenopus laevis oocytes

M. McNamee, E. Ochoa, C. Vibat, 1995, Cellular and Molecular Neurobiology.

In vitro nanobody discovery for integral membrane protein targets

G. Chang, Norman Huang, R. Doshi, 2014, Scientific Reports.

Tryptophan substitutions at the lipid-exposed transmembrane segment M4 of Torpedo californica acetylcholine receptor govern channel gating.

S. Tamamizu, M. McNamee, C. Vibat, 1996, Biochemistry.

Detection of BRAF mutations in urine and plasma cell-free DNA: Application to the diagnosis and management of histiocytic disorder patients.

M. Erlander, J. Baselga, O. Abdel-Wahab, 2014 .

Longitudinal monitoring of BRAF V600E mutation in urinary cell-free DNA of patients with metastatic cancers.

M. Erlander, F. Meric-Bernstam, Vanda M. Stepanek, 2014 .

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

M. Erlander, H. Wakelee, L. Sequist, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Highly sensitive quantitative detection of circulating tumor DNA in urine and plasma from advanced colorectal cancer patients in aid of early diagnosis of clinically relevant KRAS mutations.

M. Erlander, J. Poole, L. Benesova, 2015 .